Clinical Trial Update: Pathomolecular Analysis of Rare EGFR Mutations in Advanced NSCLC

View source ↗

Summary

Clinical trial update detailing pathomolecular analysis of rare EGFR mutations in advanced non-small cell lung cancer. The study status is listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Provitro GmbH | Conditions: Mutations in Exons 18 to 21 | Status: COMPLETED